10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 250 filers reported holding 10X GENOMICS INC in Q2 2022. The put-call ratio across all filers is 0.59 and the average weighting 1.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,647 | +124.7% | 64,162 | +204.2% | 0.03% | +233.3% |
Q2 2023 | $1,178 | +24.5% | 21,092 | +24.4% | 0.01% | -18.2% |
Q1 2023 | $946 | -9.1% | 16,957 | -40.6% | 0.01% | -15.4% |
Q4 2022 | $1,041 | -99.9% | 28,557 | -9.3% | 0.01% | +18.2% |
Q3 2022 | $897,000 | -60.6% | 31,500 | -37.3% | 0.01% | -54.2% |
Q2 2022 | $2,274,000 | +832.0% | 50,248 | +1469.8% | 0.02% | +1100.0% |
Q1 2022 | $244,000 | -93.6% | 3,201 | -87.7% | 0.00% | -88.9% |
Q3 2021 | $3,802,000 | -33.4% | 26,116 | -10.4% | 0.02% | -33.3% |
Q2 2021 | $5,705,000 | +488.1% | 29,135 | +443.8% | 0.03% | +440.0% |
Q1 2021 | $970,000 | -76.6% | 5,358 | -81.7% | 0.01% | -77.3% |
Q4 2020 | $4,139,000 | +1889.9% | 29,231 | +1650.4% | 0.02% | +2100.0% |
Q3 2020 | $208,000 | +48.6% | 1,670 | +6.4% | 0.00% | 0.0% |
Q2 2020 | $140,000 | -31.0% | 1,569 | -61.1% | 0.00% | -50.0% |
Q3 2019 | $203,000 | – | 4,029 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Venrock Management VI, LLC | 962,309 | $188,439,000 | 95.08% |
Foresite Capital Management II, LLC | 1,753,528 | $343,376,000 | 92.37% |
Foresite Capital Management I, LLC | 750,000 | $146,865,000 | 88.53% |
12 West Capital Management LP | 1,922,000 | $376,366,000 | 15.78% |
Financial Consulate Inc. | 141,258 | $27,661,000 | 9.97% |
FINANCIAL CONSULATE, INC | 141,258 | $27,661,000 | 9.97% |
Meritech Capital Associates V L.L.C. | 1,793,871 | $351,276,000 | 7.51% |
Andar Capital Management HK Ltd | 51,000 | $9,987,000 | 6.81% |
JS Capital Management LLC | 540,589 | $105,858,000 | 5.12% |
Renaissance Capital LLC | 97,281 | $19,050,000 | 3.01% |